MAM
AMED

Meeder Asset Management’s Amedisys AMED Stock Holding History

Meeder Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-641
Closed -$59.9K – 464
2023
Q3 		$59.9K Buy
+641
New +$59.2K ﹤0.01% 387
2022
Q4 		– Sell
-8
Closed -$1K – 836
2022
Q3 		$1K Sell
8
-23
-74% -$2.74K ﹤0.01% 1910
2022
Q2 		$3K Sell
31
-68
-69% -$8.69K ﹤0.01% 1770
2022
Q1 		$17K Buy
+99
New +$14.8K ﹤0.01% 1344
2021
Q4 		– Sell
-213
Closed -$32K – 1170
2021
Q3 		$32K Sell
213
-19
-8% -$3.95K ﹤0.01% 1243
2021
Q2 		$57K Sell
232
-19
-8% -$4.99K ﹤0.01% 1075
2021
Q1 		$67K Buy
251
+236
+1,573% +$66.6K ﹤0.01% 1018
2020
Q4 		$4K Sell
15
-573
-97% -$147K ﹤0.01% 1256
2020
Q3 		$139K Sell
588
-630
-52% -$143K 0.01% 698
2020
Q2 		$242K Sell
1,218
-143
-11% -$26.7K 0.02% 551
2020
Q1 		$248K Buy
1,361
+1,142
+521% +$203K 0.02% 512
2019
Q4 		$36K Buy
+219
New +$32.6K ﹤0.01% 1135
2019
Q3 		– Sell
-479
Closed -$58K – 2130
2019
Q2 		$58K Sell
479
-486
-50% -$57.7K ﹤0.01% 905
2019
Q1 		$120K Buy
965
+488
+102% +$61.2K 0.01% 652
2018
Q4 		$56K Buy
477
+247
+107% +$29.1K 0.01% 780
2018
Q3 		$28K Buy
+230
New +$25.4K ﹤0.01% 942
2018
Q1 		– Sell
-36
Closed -$2K – 1555
2017
Q4 		$2K Buy
+36
New +$1.9K ﹤0.01% 1477
2016
Q3 		– Sell
-1,906
Closed -$96K – 751
2016
Q2 		$96K Buy
+1,906
New +$96.2K 0.01% 664
2016
Q1 		– Sell
-23,935
Closed -$941K – 836
2015
Q4 		$941K Sell
23,935
-29,519
-55% -$1.18M 0.09% 198
2015
Q3 		$2.03M Buy
+53,454
New +$2.25M 0.2% 135

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Meeder Asset Management's AMED Position: Q4 2023 in Review

Meeder Asset Management sold out of Amedisys (AMED) in Q4 2023, closing a stake of 641 shares — an estimated $59.9K sold.

Meeder Asset Management first reported a position in AMED in Q3 2015 and held it in 20 quarters. The position peaked at $2.03M in Q3 2015. 287 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

  • Meeder Asset Management reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
  • Meeder Asset Management sold 641 Amedisys shares in Q4 2023, an estimated $59.9K.
  • Meeder Asset Management first reported a position in Amedisys in Q3 2015 and held it in 20 quarters.
  • Meeder Asset Management's Amedisys position peaked at $2.03M in Q3 2015.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on Meeder Asset Management's 13F filing for Q4 2023, filed 25 Jan 2024.